237 related articles for article (PubMed ID: 36266033)
1. Adjuvant Therapies for Esophageal Cancer.
Abdelhakeem A; Blum Murphy M
Thorac Surg Clin; 2022 Nov; 32(4):457-465. PubMed ID: 36266033
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant (postoperative) therapy for esophageal cancer.
Ku GY; Ilson DH
Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
[TBL] [Abstract][Full Text] [Related]
3. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
4. Trimodality Approach for Esophageal Malignancies.
Watkins AA; Zerillo JA; Kent MS
Surg Clin North Am; 2021 Jun; 101(3):453-465. PubMed ID: 34048765
[TBL] [Abstract][Full Text] [Related]
5. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancer.
Sanford NN; Catalano PJ; Enzinger PC; King BL; Bueno R; Martin NE; Hong TS; Wo JY; Mamon HJ
Dis Esophagus; 2017 Jul; 30(7):1-8. PubMed ID: 28475728
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy or chemoradiotherapy for locally advanced esophageal cancer.
Smithers BM; Thomson I
Thorac Surg Clin; 2013 Nov; 23(4):509-23. PubMed ID: 24199701
[TBL] [Abstract][Full Text] [Related]
7. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
[TBL] [Abstract][Full Text] [Related]
8. Esophageal Cancer: New Insights into a Heterogenous Disease.
Krug S; Michl P
Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
[TBL] [Abstract][Full Text] [Related]
9. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
10. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
Cohen DJ; Leichman L
J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
[TBL] [Abstract][Full Text] [Related]
11. Trimodality therapy and definitive chemoradiotherapy for esophageal cancer: a single-center experience and review of the literature.
Hategan M; Cook N; Prewett S; Hindmarsh A; Qian W; Gilligan D
Dis Esophagus; 2015 Oct; 28(7):612-8. PubMed ID: 24863560
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience.
Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725
[TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment of esophageal cancer.
Lordick F; Hölscher AH; Haustermans K; Wittekind C
Langenbecks Arch Surg; 2013 Feb; 398(2):177-87. PubMed ID: 22971784
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
15. The current status of neoadjuvant therapy for esophageal cancer.
Lin D; Leichman L
Semin Thorac Cardiovasc Surg; 2014; 26(2):102-9. PubMed ID: 25441001
[TBL] [Abstract][Full Text] [Related]
16. Current choices and prospects in management of postoperative esophageal cancer patients.
Tu CC; Hsu PK
Asian J Surg; 2019 Jan; 42(1):81-84. PubMed ID: 30121147
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and network meta-analysis: neoadjuvant chemoradiotherapy for locoregional esophageal cancer.
Huang TC; Hsu CH; Lin CC; Tu YK
Jpn J Clin Oncol; 2015 Nov; 45(11):1023-8. PubMed ID: 26246479
[TBL] [Abstract][Full Text] [Related]
18. Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancer.
Bystricky B; Okines AF; Cunningham D
Drugs; 2011 Mar; 71(5):541-55. PubMed ID: 21443280
[TBL] [Abstract][Full Text] [Related]
19. The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy.
Kim GJ; Koshy M; Hanlon AL; Horiba MN; Edelman MJ; Burrows WM; Battafarano RJ; Suntharalingam M
Am J Clin Oncol; 2016 Apr; 39(2):136-41. PubMed ID: 24487417
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.
Hammoud ZT; Kesler KA; Ferguson MK; Battafarrano RJ; Bhogaraju A; Hanna N; Govindan R; Mauer AA; Yu M; Einhorn LH
Dis Esophagus; 2006; 19(2):69-72. PubMed ID: 16643172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
